Your browser doesn't support javascript.
loading
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.
Zeligs, Kristen P; Morelli, Maria Pia; David, Justin M; Neuman, Monica; Hernandez, Lidia; Hewitt, Stephen; Ozaki, Michelle; Osei-Tutu, Akosua; Anderson, David; Andresson, Thorkell; Das, Sudipto; Lack, Justin; Abdelmaksoud, Abdalla; Fantini, Massimo; Arlen, Philip M; Tsang, Kwong Y; Annunziata, Christina M.
Affiliation
  • Zeligs KP; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Morelli MP; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • David JM; Precision Biologics, Inc., Bethesda, MD, United States.
  • Neuman M; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Hernandez L; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Hewitt S; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Ozaki M; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Osei-Tutu A; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Anderson D; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Andresson T; Protein Characterization Laboratory of the Cancer Research Program (CRTP)/Mass Spectrometry Center, National Institutes of Health, Fredrick, MD, United States.
  • Das S; Protein Characterization Laboratory of the Cancer Research Program (CRTP)/Mass Spectrometry Center, National Institutes of Health, Fredrick, MD, United States.
  • Lack J; NIAID Collaborative Bioinformatics Resource (NCBR), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
  • Abdelmaksoud A; Frederick National Laboratory for Cancer Research, Advanced Biomedical Computational Science, Fredrick, MD, United States.
  • Fantini M; Frederick National Laboratory for Cancer Research, Advanced Biomedical Computational Science, Fredrick, MD, United States.
  • Arlen PM; Frederick National Laboratory for Cancer Research, CCR Collaborative Bioinformatics Resource, Fredrick, MD, United States.
  • Tsang KY; Precision Biologics, Inc., Bethesda, MD, United States.
  • Annunziata CM; Precision Biologics, Inc., Bethesda, MD, United States.
Front Oncol ; 10: 805, 2020.
Article in En | MEDLINE | ID: mdl-32637350
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2020 Type: Article Affiliation country: United States